May 11, 2010 - Indianapolis medical device firm receives FDA clearance for respiratory product – SonarMed™, a developer and manufacturer of critical care respiratory monitoring technologies, announced that it has received Food and Drug Administration clearance for its patented SonarMed™ Airway Monitoring System (AMS), which monitors breathing tubes for patients requiring ventilators.The SonarMed AMS uses acoustic reflection technology to provide precise, real-time monitoring of breathing tubes. The system may be used to assist clinicians in preventing and detecting conditions that can harm the patient, such as movement of the breathing tube, which can result in ventilation failure or lung damage, and obstruction of the breathing tube, which can deprive the patient of needed oxygen. Compared with the conventional standards of care and available patient information, having this type of adjunctive information about the breathing tube provides clinicians with a more immediate and complete picture of the patient’s respiratory support status... [PDF] SonarMed's Press Release -
